Background HCV recurrence after liver transplant is nearly universal and results in progressive fibrosis,cirrhosis, graft loss, re transplantation and mortality.There are very few studies comparing impact of pre transplant HCC therapies either as a bridge to transplant or to downstage like TACE, hepatectomy ,RFA, PEI on HCV recurrence post transplant.